Firm seeks NIH grant to conduct study of epilepsy Dx tool

04/30/2013 | MedCityNews.com

A pair of doctors who founded Cognizance Biomarkers are working on a blood-based test to detect epilepsy more precisely and reduce overdiagnosis of the condition. The firm is applying for NIH funding to conduct a proof of principle study for the assay, which is intended to locate an anti-inflammatory protein originating from the brain that is often found in low concentrations in epilepsy patients.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA